Patients Drop MS Drug (Tysabri), Face Relapse Risk
This report is part of a 12-month Clinical Context series. By John Gever, Senior Editor, MedPage Today Published: April 25, 2012…
Patient on Novartis’ multiple sclerosis drug gets rare brain disease – PML…
Published April 13, 2012 The Wall Street Journal BASEL, Switzerland – Novartis said Friday a patient treated with its multiple…
Stuart Schlossman
STRATIFY JCV is a blood test that detects anti-JC virus (JCV) antibodies to help assess the risk of PML in patients with MS
If you are unable to read the HTML email below, please view it online. Visit STRATIFYJCV.com/US to watch an educational…
Stuart Schlossman
Immunological Markers of Optimal Response to Natalizumab (Tysabri) in Multiple Sclerosis
Luisa M. Villar, PhD; María I. García-Sánchez, PhD; Lucienne Costa-Frossard, MD; Mercedes Espiño, PhD; Ernesto Roldán, PhD; Dolores Páramo, MD; Miguel Lucas, PhD;Guillermo Izquierdo, …
Stuart Schlossman
An MS Patient’s story on PML
Angela created the video found here in October 2010. This video is very informative and so, I needed to share…
Stuart Schlossman
Phase 3b Trial Evaluates Tysabri as MS Treatment for Secondary Progressive MS (SPMS)
Biogen Idec and Elan Corporation announced a global Phase 3b study that is being conducted to evaluate the effectiveness of…
Stuart Schlossman
FDA approves test to screen Tysabri patients
The Food and Drug Administration on Friday approved a new diagnostic test to help identify patients who have an increased…
Stuart Schlossman
The FDA has approved the first test for assessing the risk of progressive multifocal leukoencephalopathy (PML) in patients on natalizumab (Tysabri)
By Kristina Fiore, Staff Writer, MedPage Today Published: January 20, 2012 SOURCE: Medical News Today The Stratify JCV Antibody ELISA test screens…
Stuart Schlossman
Study Shows Potential of Lab Test to Detect Virus Which Causes PML in People with MS – ongoing study may help identify risk for PML in people treated with natalizumab
Biogen Idec researchers have published results on a blood test that detects antibodies to the JC virus, the virus responsible…
Stuart Schlossman
Natalizumab an Option for Pediatric MS?
November 7, 2011 (Amsterdam, the Netherlands) — A new study suggests that natalizumab (Tysabri, Biogen Idec/Elan) may be an effective…
Stuart Schlossman
